Spatial Analysis Startup Resolve Biosciences Launches With $24M Series A Financing Round

Dec 10, 2020

|

NEW YORK – Resolve Biosciences, a startup developing a spatial multiomics analysis platform, emerged from stealth on Thursday and announced it has raised a $24 million Series A financing round.

PS Capital Management and Mastermind Advisory Services led the round, joined by Alafi Capital, John Shoffner, and High Tech Gründerfonds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Worries About Increased Deadliness

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

Merck Stops SARS-CoV-2 Vaccine Development

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

PLOS Papers on Rare Venous Thromboembolism Variant, Vector Mosquito LncRNAs, More

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.

Menu

Spatial Analysis Startup Resolve Biosciences Launches With $24M Series A Financing Round

To read the full story....

Breaking News

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Split Biosciences Rebrands as Parse Biosciences, Raises $7M in Series A Financing

Hypertrophic Cardiomyopathy Studies Reveal Common Contributors, Risk Score

Machine Learning Tool Uncovers Novel Endogenous Viruses in Human Genome

Todos Medical Obtains $3.4M Investment From Yozma Group Korea

Infectious Disease Test Firm Talis Biomedical Files for IPO

The Scan

Should Also Work

Worries About Increased Deadliness

Merck Stops SARS-CoV-2 Vaccine Development

PLOS Papers on Rare Venous Thromboembolism Variant, Vector Mosquito LncRNAs, More

What's Popular?

Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates

Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics

Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

Lucira Health Files for $115M IPO

People in the News: New Appointments at Foundation Medicine, Sophia Genetics, Circulogene; More

Sponsorships